Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
Bush, WS, Crosslin, DR, Owusu‐Obeng, A, Wallace, J, Almoguera, B, Basford, MA, Bielinski, SJ, Carrell, DS, Connolly, JJ, Crawford, D, Doheny, KF, Gallego, CJ, Gordon, AS, Keating, B, Kirby, J, Kitchner, T, Manzi, S, Mejia, AR, Pan, V, Perry, CL, Peterson, JF, Prows, CA, Ralston, J, Scott, SA, Scrol, A, Smith, M, Stallings, SC, Veldhuizen, T, Wolf, W, Volpi, S, Wiley, K, Li, R, Manolio, T, Bottinger, E, Brilliant, MH, Carey, D, Chisholm, RL, Chute, CG, Haines, JL, Hakonarson, H, Harley, JB, Holm, IA, Kullo, IJ, Jarvik, GP, Larson, EB, McCarty, CA, Williams, MS, Denny, JC, Rasmussen‐Torvik, LJ, Roden, DM, Ritchie, MD
Published in Clinical pharmacology and therapeutics (01.08.2016)
Published in Clinical pharmacology and therapeutics (01.08.2016)
Get full text
Journal Article
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems
Rasmussen-Torvik, L J, Stallings, S C, Gordon, A S, Almoguera, B, Basford, M A, Bielinski, S J, Brautbar, A, Brilliant, M H, Carrell, D S, Connolly, J J, Crosslin, D R, Doheny, K F, Gallego, C J, Gottesman, O, Kim, D S, Leppig, K A, Li, R, Lin, S, Manzi, S, Mejia, A R, Pacheco, J A, Pan, V, Pathak, J, Perry, C L, Peterson, J F, Prows, C A, Ralston, J, Rasmussen, L V, Ritchie, M D, Sadhasivam, S, Scott, S A, Smith, M, Vega, A, Vinks, A A, Volpi, S, Wolf, W A, Bottinger, E, Chisholm, R L, Chute, C G, Haines, J L, Harley, J B, Keating, B, Holm, I A, Kullo, I J, Jarvik, G P, Larson, E B, Manolio, T, McCarty, C A, Nickerson, D A, Scherer, S E, Williams, M S, Roden, D M, Denny, J C
Published in Clinical pharmacology and therapeutics (01.10.2014)
Published in Clinical pharmacology and therapeutics (01.10.2014)
Get more information
Journal Article
Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
Roberts, Thomas G, Goulart, Bernardo H, Squitieri, Lee, Stallings, Sarah C, Halpern, Elkan F, Chabner, Bruce A, Gazelle, G. Scott, Finkelstein, Stan N, Clark, Jeffrey W
Published in JAMA : the journal of the American Medical Association (03.11.2004)
Published in JAMA : the journal of the American Medical Association (03.11.2004)
Get full text
Journal Article
Analysis of over 2,400 modern phase I cancer trials: Composition, outcomes, and use of surrogate endpoints
Roberts, T. G., Goulart, B. H. L., Stallings, S. C., Squitieri, L., Chabner, B. A., Finkelstein, S. N., Clark, J. W.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Analysis of over 2,400 modern phase I cancer trials: Composition, outcomes, and use of surrogate endpoints
Roberts, T. G., Goulart, B. H. L., Stallings, S. C., Squitieri, L., Chabner, B. A., Finkelstein, S. N., Clark, J. W.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Who'll be first? Genomic biomarkers impact on drug discovery and clinical practice
Get full text
Journal Article
Conference Proceeding
The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans
Ozminkowski, Ronald J., Marder, William D., Hawkins, Kevin, Wang, Shaohung, Stallings, Sarah C., Finkelstein, Stan N., Sinskey, Anthony J., Wierz, David
Published in Clinical therapeutics (01.08.2004)
Published in Clinical therapeutics (01.08.2004)
Get full text
Journal Article
PCN5 ANALYSIS OF OVER 2400 MODERN PHASE I CANCER TRIALS: COMPOSITION, OUTCOMES, AND USE OF SURROGATE ENDPOINTS
Roberts, TG, Goulart, BHL, Stallings, SC, Squitieri, L, Chabner, BA, Finkelstein, SN, Clark, JW
Published in Value in health (01.05.2004)
Published in Value in health (01.05.2004)
Get full text
Journal Article